MaimoniDex RA Ltd.
|
|
|
|
Swansea. UK |
| |
|
|
+44-77-9123-5930 |
|
|
+44-1792-602-500 |
|
|
|
|
|
|
|
|
|
developing a humanized monoclonal antibody (mAb); anti-CD44vRA. Anti-CD44vRA mAb selectively targets the pathological cells involved in the inflammatory process | |
Korean Distributor : ??? |
Products information :
|
|
|
|
|
|
|
|
|
|